[1]CurrentPatentAssignee:BAYERAG-US2020/79765,2020,A1Locationinpatent:Paragraph0196-0197
[2]CurrentPatentAssignee:BAYERAG-US2020/95241,2020,A1Locationinpatent:Paragraph0248-0249
[1]Patent:US2020/95241,2020,A1.Locationinpatent:Paragraph0230-0231
17467-35-5
762272-35-5
1538401-81-8
1501401-72-4
1153977-87-7
40311-13-5 | 6-Fluoro-2-methyl-1h-indole | AA00C752 | MFCD09027714
4045-25-4 | 4-Methoxypiperidine, HCl | AA00C7CB | MFCD06800959
400720-05-0 | (1S,2S,5R)-3-(tert-Butoxycarbonyl)-3-azabicyclo[3.1.0]hexane-2-carboxylic acid | AA00C7JF | MFCD08460285
36894-69-6 | Labetalol | AA00C7RP | MFCD00242941
380-44-9 | Allyl 2-chloro-1,1,2-trifluoroethyl ether | AA00C802 | MFCD00039336
3527-19-3 | 1H-Benzimidazol-5-amine,1,2-dimethyl-(9CI) | AA00C84J | MFCD03872210
3535-35-1 | 4-Isobutoxy-3-methoxy-benzoic acid | AA00C880 | MFCD03951031
423768-56-3 | 5-Methyl-1-(2-methylphenyl)-1h-pyrazole-4-carboxylic acid | AA00C8C6 | MFCD03407350
42195-97-1 | 4-Ethylcyclohexanamine | AA00C8GC | MFCD04969087
33860-28-5 | 4-Methylpiperazine-1-carbothioamide | AA00C8L1 | MFCD04116805